SGLT-2 inhibitors may be targeting higher risk patients with diabetes possibly justifying higher cost: Single center repeated cross-sectional analysis
Keyword(s):
2018 ◽
Vol 16
(2)
◽
pp. 168-175
◽
2016 ◽
Vol Volume 12
◽
pp. 1893-1900
◽
2021 ◽
Vol Volume 14
◽
pp. 2893-2903
Keyword(s):
Keyword(s):
2012 ◽
Vol 58
(4)
◽
pp. 472-476
◽